Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study
Article in Toxins (April 2024)
The most recent citing publications are shown below. View all 93 publications that cite this research output on Dimensions.
Article in Toxins (April 2024)
Article in The Journal of Headache and Pain (April 2024)
Article in Sleep Medicine (March 2024)